Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2023-04-05 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Celebrates Expansion into New Distribution Facility in the US
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' dated 05.04.2023 announcing the grand opening and expansion of a distribution facility in the US. It contains operational updates, quotes from the CEO and General Manager, and contact information. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report, fits best under the general category for regulatory announcements or news releases that don't fit other specific categories. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news announcement of this nature, as it is a public disclosure but not a specific financial report type listed (like ER, IR, 10-K, etc.). It is too detailed to be a simple Report Publication Announcement (RPA) which usually just points to another document.
2023-04-05 English
Medacta publishes 2023 Annual General Meeting invitation
AGM Information Classification · 1% confidence The document explicitly states, 'Medacta publishes 2023 Annual General Meeting invitation' multiple times. It details the date, time, location of the Annual General Meeting (AGM), and lists the motions to be voted upon, such as dividend distribution and re-election of board members. This content directly relates to the preparation and announcement for the AGM. Therefore, the classification is AGM-R (AGM Information). The document is an invitation/announcement, not the voting results (DVA) or a proxy statement (PSI), but the core subject is the AGM itself.
2023-03-29 English
Medacta publishes 2023 Annual General Meeting invitation
AGM Information Classification · 1% confidence The document explicitly states, 'Medacta publishes 2023 Annual General Meeting invitation' and discusses the details of the upcoming Annual General Meeting (AGM), including the date, location, proposals for re-election, dividend proposals, and amendments to the Articles of Association. This content is directly related to the preparation and announcement of the AGM. The definition for AGM Information (AGM-R) covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. Although this is an invitation/announcement, the core subject matter is the AGM itself, making AGM-R the most specific fit over a general RPA or RNS, as it details the agenda items and proposals to be voted on at that specific meeting.
2023-03-29 English
New clinical study demonstrates Medactas MySpine accuracy in screw replacement during spine revision surgery
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' from Medacta Group SA announcing the 'publication of a new retrospective landmark study' regarding their MySpine system. It details study results, quotes a professor, and provides citations for the published study. This is not a formal regulatory filing like a 10-K, nor is it a transcript (CT) or a formal earnings release (ER). It is an announcement of new information, specifically related to clinical/research findings, which often falls under general corporate news or investor relations material. Since there is no specific category for 'Study Results Announcement' and it is not a formal financial report, it best fits the general 'Regulatory Filings' (RNS) category as a broad corporate announcement, or potentially an 'Investor Presentation' (IP) if it were a presentation deck, but here it reads like a press release about research. Given the options, RNS serves as the best general regulatory/corporate news fallback for non-standard announcements.
2023-03-20 English
New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
Regulatory Filings Classification · 1% confidence The document is titled 'MEDIA RELEASE' and announces the publication of a new clinical study regarding the company's MySpine product. It contains key highlights, quotes from a professor, and references to the study's publication date and location. This format strongly suggests an initial announcement of results or news, rather than the full financial report (10-K, IR) or the transcript of a call (CT). Since it is an announcement of clinical study results, it is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but given the format, RNS is the most appropriate general category for non-financial, non-management/board specific news releases that don't fit other specific categories like DIRS or DIV. However, since the content is about study results, and there is no specific category for 'Study Results Announcement', RNS serves as the best fit for a general regulatory/news announcement.
2023-03-20 English
Medacta Group SA: 2022 Full Year Results
Earnings Release Classification · 1% confidence The document is explicitly titled "Medacta Group SA: 2022 Full Year Results" and contains detailed financial figures for the full year ended 31 December 2022, including Revenue, Adjusted EBITDA, Profit for the year, and Balance Sheet data. This content strongly indicates a primary financial results announcement. However, the document is structured as an 'Ad-hoc announcement pursuant to Art. 53 LR' and includes a link to the full 'Medacta 2022 Annual Report'. Since this document provides the key highlights and results summary, it fits the definition of an Earnings Release (ER). While it covers the full year, the format is that of an initial release/summary, not the comprehensive 10-K filing itself. Furthermore, it announces the upcoming Annual General Meeting (AGM) and provides details for the results webcast, typical of an ER. Given the focus on reporting the '2022 Full Year Results' highlights, ER is the most appropriate classification over 10-K (which is the formal filing) or IR (Interim Report, which is for shorter periods). FY 2022
2023-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.